ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Hanyang, Seoul

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Rhinitis
Chronic Obstructive Pulmonary Disease
Dust Mite Allergy
Lung Diseases
Disease

Asthma trials near Hanyang, Seoul, KOR:

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...

Enrolling
Asthma
Drug: Placebo
Drug: Benralizumab

Phase 3

AstraZeneca
AstraZeneca

Seoul, South Korea and 116 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Seoul, South Korea and 335 other locations

Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and wor...

Enrolling
Asthma
Biological: Depemokimab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Seoul, South Korea and 49 other locations

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...

Enrolling
Asthma
Biological: Tezepelumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Seoul, South Korea and 142 other locations

The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...

Active, not recruiting
Severe Asthma
Drug: Verekitug
Drug: Placebo

Phase 2

Upstream Bio

Seoul, South Korea, South Korea and 101 other locations

This is a study of amlitelimab for the treatment of participants with moderate-to-severe asthma. The study will have a double-blind treatmen...

Active, not recruiting
Asthma
Drug: Placebo
Drug: Amlitelimab

Phase 2

Sanofi
Sanofi

Seoul, Seoul-teukbyeolsi, South Korea and 69 other locations

PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, ...

Enrolling
Asthma
Other: Placebo
Drug: PF-07275315

Phase 2

Pfizer
Pfizer

Seoul, Seoul-teukbyeolsi [seoul], South Korea and 131 other locations

trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...

Active, not recruiting
Asthma
Drug: Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate
Drug: Inhaled corticosteroids/long-acting beta-2 agonists

Phase 4

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Seoul, South Korea and 116 other locations

This study aims to compare the efficacy and safety of DW1807 and DW1807-R2 in patients with perennial allergic rhinitis and comorbid asthma....

Enrolling
Perennial Allergic Rhinitis Accompanied by Asthma
Drug: Experimental
Drug: Comparator

Phase 3

Daewon Pharmaceutical
Daewon Pharmaceutical

Seoul, South Korea

This is a phase 2, open-label extension study to evaluate the long-term safety and efficacy of lunsekimig in adult participants with asthma ...

Invitation-only
Asthma
Drug: Lunsekimig

Phase 2

Sanofi
Sanofi

Seoul, Seoul-teukbyeolsi, South Korea and 129 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems